tacrine has been researched along with Psychotic Disorders in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zapletálek, M | 1 |
| Hanus, H | 1 |
| Fusek, J | 1 |
| Hrdina, V | 1 |
1 other study available for tacrine and Psychotic Disorders
| Article | Year |
|---|---|
First experience with the application of 7-methoxytacrine to psychiatric patients.
Topics: Adult; Aminoacridines; Antipsychotic Agents; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; Fe | 1989 |